The Role of ERP in the Pharmaceutical Industry

Navigator SAP

The pharmaceutical industry has been transformed in recent years by pressure from intensely competitive markets and the need to comply with new regulations that mandate the highest quality standards across all processes. Life Sciences ERP Software Pharmaceutical

Why SAP ERP Makes Sense for Pharmaceutical Manufacturing

Navigator SAP

Legacy software systems no longer make sense for life sciences businesses, especially those in Pharmaceutical manufacturing. The problem is that complexity, regulation, and competition have changed how pharmaceutical and life sciences firms must do business.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Operational Challenges In The Pharmaceutical Industry

Navigator SAP

Without the robust pharmaceutical sector, many people throughout the world would have been wiped out long ago by even mild illnesses. PharmaceuticalUnfortunately, this industry is constantly facing many challenges, most of which are operational.

Why Is Traceability Important In The Pharmaceutical Industry?

Navigator SAP

Consumer health and safety is the fundamental responsibility of a pharmaceutical company. To avoid this, the pharmaceutical supply chain is one of the most heavily regulated supply chains in the world. Life Sciences Traceability Pharmaceutical

What is an ERP System in the Pharmaceutical industry?

Navigator SAP

The flow of processes and operations in a pharmaceutical company is extremely complex and labor-intensive, owing to stringent production regulations and competitive market demands. Life Sciences ERP Software Pharmaceutical

How to Improve Quality Control in the Pharmaceutical Industry

Navigator SAP

Life Sciences PharmaceuticalQuality plays a pivotal role in the success of any business. Delays in delivery are often caused by products not meeting the mandated quality standards.

Advancing real-world evidence for pharmaceutical companies in Japan

McKinsey

Insights on Life Sciences Pharmaceuticals JapanPharma companies in Japan have an opportunity to obtain value from real-world evidence using advanced analytics and to better ensure patient outcomes.

Developing pharmaceutical launch leaders and company-wide capabilities at scale

McKinsey Public & Social Sector Insights

Insights on Life Sciences PharmaceuticalsBy building certain functional and leadership skills, pharma companies can not only improve the odds of a successful launch but also strengthen their organizations for the future.

FCF Pharmaceutical Market Study – 2021 published

Fox Corporate Finance

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Pharmaceutical Market Study – 2021”. Based on available data from European pharmaceutical providers, the FCF Pharmaceutical Market Study is a detailed and comprehensive.

CDMOs, CMOs and CROs: What's the Difference?

Navigator SAP

The pharmaceutical industry has undergone significant evolution within the past 15 years. Pharmaceutical CDMOsRecently, biopharmaceutical companies have become increasingly reliant on outsourced contract services for various elements of their value chain.

SAP 207

Alibaba Raises $1.3B For Push Into eCommerce Pharmaceutical Business

PYMNTS

billion it raised in a secondary offering on the Hong Kong stock exchange to expand its eCommerce pharmaceutical business as it rides a wave of growth amid the coronavirus. Alibaba Health Information Technology plans to pump the $1.3

A Chronic Disease Still Waiting for a Drug

CFO News Room

Take Intercept Pharmaceuticals which at the height of the Wall Street excitement over NASH treatments fetched as much as $462 a share. Drug companies have developed treatments for some of the rarest diseases afflicting a tiny percentage of the population, yet they have failed repeatedly to get a drug on the market for a chronic and increasingly common one.

Supplylogix Secures Pharmaceutical Inventory Management Patent

PYMNTS

The company targets the pharmaceutical industry, and its patent will enable industry players to transfer inventory of medications based on demand, the firm said. “We The pharmaceutical industry is active in the exploration of tech and FinTech to enhance supply chain and other business management processes. B2B Payments B2B inventory management logistics News patent pharmaceuticals Supplylogix What's Hot In B2B

Johnson & Johnson Sales Rise 8.3 Pct Amid Consumer Health, Pharmaceutical Growth

PYMNTS

percent from Q4 2019 to Q4 2020, as consumer health and pharmaceutical sales rose while medical devices worldwide operational sales fell amid the pandemic. It reported that pharmaceutical worldwide operational sales grew by 8.4 Johnson & Johnson reported on Tuesday (Jan.

Snap Seeks Ads From Pharmaceutical Companies

PYMNTS

In an effort to have big pharma companies advertise on Snapchat , the social media platform is reportedly pitching itself as a friendlier alternative to Twitter and Facebook. The idea is that younger people might be more open to ads focusing on health matters — and may be more comfortable talking about private matters on the platform, CNBC reported. The social media company had a team speak at the DigiPharma Connect conference in February.

IBM Targets Pharmaceuticals With Blockchain Supply Chain Tech

PYMNTS

As IBM continues its exploration of how blockchain could disrupt supply chain management, the technology firm has partnered with Hejia to introduce a solution targeting the pharmaceutical space. Reports this week said the companies have together launched a blockchain-based supply chain finance solution targeting procurement processes in pharmaceuticals.

Cloud Computing in Pharma

Navigator SAP

One industry that is slowly adopting cloud computing technology is the pharmaceutical sector. The uptake of this technology in the pharmaceutical industry remains somewhat measured due to strict protocols and compliance regulations. cloud computing Pharmaceutical

SAP 130

Pfizer to Buy Rest of Biohaven for $11.6 Billion

CFO News Room

Pfizer on Tuesday said it agreed to buy the rest of Biohaven Pharmaceutical Holding for about $11.6 billion, giving the New York drugmaker full ownership of the Nurtec ODT migraine franchise. Pfizer said it would pay $148.50

Developing a customer-centric approach to rare conditions

McKinsey Public & Social Sector Insights

Roche Pharmaceuticals’ approach to rare conditions highlights industry efforts to make a difference for patients, their caregivers, and healthcare professionals. Insights on Life Sciences Pharmaceuticals Medical products

Fewer Cures, Costlier Energy – WSJ

CFO News Room

The bill has many moving parts, but here’s a simple way to sum up its macroeconomic impact: It would transfer about a quarter of a trillion dollars from America’s pharmaceutical industry, which saves and extends lives, to the climate-change industrial complex, which makes energy more expensive. By Stephen Moore and Tomas J. Philipson. 7, 2022 12:52 pm ET. The so-called Inflation Reduction Act will be one of the greatest misallocations of federal resources in American history.

What is SOX Compliance in Pharma?

Navigator SAP

Life Sciences PharmaceuticalAutomation of key business processes in the life science industry has profound benefits. SAP ERP is one such tool that allows companies in the life science industry to do just that.

GMP Guidelines in Pharma Industry

Navigator SAP

The pharmaceutical industry is one of the most heavily regulated industries due to the implications product quality has on public health. Life Sciences Bio Pharma Pharmaceutical

SAP 130

Johnson & Johnson, Drug Distributors Agree to Opioid Settlement With States

CFO News Room

Pharmaceutical company Johnson & Johnson and three of the nation’s biggest drug distributors have agreed to move forward with a landmark settlement with a majority of states, bringing thousands of lawsuits over the opioid epidemic closer to the finish line.

Biotech Stocks, Once Booming, Enter Bear Territory

CFO News Room

Biotech companies are having one of their worst stock-market runs in years, as rising interest rates, scientific setbacks and a slowdown in big pharma buyouts batter the sector.

Health equity: A framework for the epidemiology of care

McKinsey

Pharmaceutical and life sciences companies can unlock new opportunities, help underserved patients, and build a cycle of trust. Insights on Life Sciences Health care reform Pharmaceuticals

Western Drugmakers Are Still Providing Medicines to Russia

CFO News Room

pharmaceutical products last year, according to. Russian pharmaceutical companies are struggling to import the main ingredients, said Pavel Rasshchupkin, RNC’s commercial director.

Pfizer’s Covid-19 Booster Cleared for 5- to 11-Year-Olds

CFO News Room

The authorization by U.S. health regulators expands booster access to about 28 million youngsters. Source link.

Eight imperatives for launching cell and gene therapies

McKinsey Public & Social Sector Insights

Insights on Life Sciences Medical products PharmaceuticalsCompanies launching new cell and gene therapies can live up to their promise of transforming patient lives through proper preparation of the market, their products, and internal go-to-market models.

Five ways that life science companies can build tech talent

McKinsey Public & Social Sector Insights

Insights on Life Sciences Health Care Pharmaceuticals DigitalFor life science companies to meet their digital ambitions, they must strengthen their technology skills. In a challenging market, emphasizing value propositions can attract first-rate talent.

Against the odds: How life sciences companies excel in large transformations

McKinsey Public & Social Sector Insights

Insights on Life Sciences Pharmaceuticals Performance transformationLife sciences companies pursuing a step change in performance have obtained mixed results. Adhering to five principles can greatly improve the odds of a large transformation program succeeding.

GameStop, Rivian, Regeneron, Snap and more

CFO News Room

after the pharmaceutical stock posted positive results from a trial for a potential eye drug. Pedestrians pass in front of a GameStop retail store in New York, December 23, 2021. Scott Mlyn | CNBC. Check out the companies making headlines in midday trading Thursday.

CFO 130

Women in healthcare and life sciences: The ongoing stress of COVID-19

McKinsey

Insights on Healthcare Systems & Services Health care providers PharmaceuticalsThe healthcare sector is examining how to better hire and promote women to the highest levels.

Baby-Formula Ingredient Supplies Are Limited by War in Ukraine

CFO News Room

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by. our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact. Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. link].

Alzheimer’s Researchers Probe New Treatment Paths

CFO News Room

The commercial failure of Biogen Inc.’s s drug Aduhelm is putting new focus on the state of research into the causes of Alzheimer’s disease. More than six million people in the U.S. are living with the progressive type of dementia, according to the Alzheimer’s Association, an advocacy group.

Zscaler, DocuSign, Virgin Galactic, Kroger and more

CFO News Room

Regeneron Pharmaceuticals — The pharmaceutical stock gained 2.2% The Kroger supermarket chain’s headquarters is shown in Cincinnati, Ohio. Lisa Baertlein | Reuters. Check out the companies making headlines in midday trading Friday. Zscaler — Zscaler surged 21.9%

CFO 130